Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

20181,266 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 393, Issue 10166, pp. 40-50

Field-Weighted Citation Impact: 116.22